Catinazzo Thomas — SEC insider filings

SEC reporting owner CIK 1818261. 59 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers the 50 most recent of 59 filings on record, filed 2021-12-27 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Relay Therapeutics, Inc. (RLAY)Chief Financial Officer50—65 legs · 586,699 sh · $8,176,56421

Insider filings — Catinazzo Thomas

FiledFormIssuerReported transactionsSource
2026-11-204Relay Therapeutics, Inc. (RLAY)Sale (S): 32,717 @ $16.51EDGAR
2026-10-304Relay Therapeutics, Inc. (RLAY)Sale (S): 1,469 @ $18.62EDGAR
2026-10-084Relay Therapeutics, Inc. (RLAY)Sale (S): 17,511 @ $18.58 · Sale (S): 206 @ $19.26EDGAR
2026-09-094Relay Therapeutics, Inc. (RLAY)Sale (S): 17,717 @ $18.94EDGAR
2026-08-184Relay Therapeutics, Inc. (RLAY)Sale (S): 17,717 @ $19.74EDGAR
2026-07-304Relay Therapeutics, Inc. (RLAY)Sale (S): 1,459 @ $18.61EDGAR
2026-07-084Relay Therapeutics, Inc. (RLAY)Sale (S): 17,717 @ $18.69EDGAR
2026-06-244Relay Therapeutics, Inc. (RLAY)Sale (S): 17,717 @ $17.01 · Option exercise (M): 56,323 @ $5.04 · Sale (S): 56,323 @ $16.97 · Option exercise (M): 61,563 @ $5.22 · Sale (S): 61,563 @ $16.97 · Option exercise (M): 51,560 @ $4.45 · +4 moreEDGAR
2026-05-144Relay Therapeutics, Inc. (RLAY)Sale (S): 17,717 @ $12.86EDGAR
2026-04-304Relay Therapeutics, Inc. (RLAY)Sale (S): 972 @ $14.79EDGAR
2026-04-094Relay Therapeutics, Inc. (RLAY)Sale (S): 17,717 @ $13.01 · Option exercise (M): 1,800 @ $5.22 · Sale (S): 1,800 @ $15 · Option exercise (M): 1,800 (derivative) @ $0EDGAR
2026-03-114Relay Therapeutics, Inc. (RLAY)Sale (S): 17,717 @ $10.06EDGAR
2026-01-294Relay Therapeutics, Inc. (RLAY)Sale (S): 13,820 @ $7.62 · Sale (S): 1,695 @ $8.45EDGAR
2026-01-154Relay Therapeutics, Inc. (RLAY)Grant/award (A): 400,000 (derivative) @ $0EDGAR
2025-10-304Relay Therapeutics, Inc. (RLAY)Sale (S): 21,664 @ $7.29EDGAR
2025-07-304Relay Therapeutics, Inc. (RLAY)Sale (S): 1,701 @ $3.74 · Sale (S): 18,380 @ $3.68EDGAR
2025-04-304Relay Therapeutics, Inc. (RLAY)Sale (S): 1,709 @ $3.17 · Sale (S): 981 @ $3.17 · Sale (S): 3,558 @ $3.23 · Sale (S): 12,943 @ $3EDGAR
2025-03-314Relay Therapeutics, Inc. (RLAY)Sale (S): 298 @ $2.84 · Sale (S): 4,566 @ $2.84EDGAR
2025-01-304Relay Therapeutics, Inc. (RLAY)Sale (S): 33,753 @ $4.63 · Sale (S): 2,283 @ $4.63 · Grant/award (A): 139,141 @ $0 · Sale (S): 2,109 @ $4.55 · Sale (S): 20,791 @ $4.42EDGAR
2025-01-144Relay Therapeutics, Inc. (RLAY)Grant/award (A): 275,000 (derivative) @ $0EDGAR
2024-12-314Relay Therapeutics, Inc. (RLAY)Sale (S): 299 @ $4.38 · Sale (S): 4,566 @ $4.42EDGAR
2024-10-304Relay Therapeutics, Inc. (RLAY)Sale (S): 1,697 @ $6.06 · Sale (S): 5,105 @ $6.06 · Sale (S): 2,300 @ $5.95EDGAR
2024-10-014Relay Therapeutics, Inc. (RLAY)Sale (S): 295 @ $7.51 · Sale (S): 6,162 @ $7.46EDGAR
2024-07-314Relay Therapeutics, Inc. (RLAY)Sale (S): 1,702 @ $8.85 · Sale (S): 9,078 @ $8.51EDGAR
2024-07-014Relay Therapeutics, Inc. (RLAY)Sale (S): 295 @ $6.26 · Sale (S): 9,078 @ $6.24EDGAR
2024-04-294Relay Therapeutics, Inc. (RLAY)Sale (S): 1,695 @ $6.38EDGAR
2024-03-294Relay Therapeutics, Inc. (RLAY)Sale (S): 348 @ $7.70EDGAR
2024-01-314Relay Therapeutics, Inc. (RLAY)Sale (S): 2,005 @ $9.64EDGAR
2024-01-184Relay Therapeutics, Inc. (RLAY)Grant/award (A): 200,000 @ $0EDGAR
2023-12-294Relay Therapeutics, Inc. (RLAY)Sale (S): 294 @ $11.51EDGAR
2023-11-014Relay Therapeutics, Inc. (RLAY)Sale (S): 1,697 @ $6.03EDGAR
2023-09-294Relay Therapeutics, Inc. (RLAY)Sale (S): 294 @ $8.38EDGAR
2023-07-314Relay Therapeutics, Inc. (RLAY)Sale (S): 1,693 @ $11.80EDGAR
2023-06-284Relay Therapeutics, Inc. (RLAY)Sale (S): 294 @ $12.12EDGAR
2023-06-014/ARelay Therapeutics, Inc. (RLAY)Sale (S): 2,012 @ $11.16EDGAR
2023-05-014Relay Therapeutics, Inc. (RLAY)Sale (S): 863 @ $11.16EDGAR
2023-03-284Relay Therapeutics, Inc. (RLAY)Sale (S): 347 @ $15.36EDGAR
2023-01-314Relay Therapeutics, Inc. (RLAY)Sale (S): 864 @ $21.56EDGAR
2023-01-194Relay Therapeutics, Inc. (RLAY)Grant/award (A): 101,115 @ $0 · Grant/award (A): 104,600 (derivative) @ $0 · Grant/award (A): 97,630 (derivative) @ $0EDGAR
2022-12-284Relay Therapeutics, Inc. (RLAY)Sale (S): 445 @ $14.49EDGAR
2022-11-014Relay Therapeutics, Inc. (RLAY)Sale (S): 1,099 @ $21.54EDGAR
2022-09-294Relay Therapeutics, Inc. (RLAY)Sale (S): 443 @ $22.73EDGAR
2022-09-084Relay Therapeutics, Inc. (RLAY)Option exercise (M): 26,257 @ $4.12 · Sale (S): 26,257 @ $30 · Option exercise (M): 26,257 (derivative) @ $0EDGAR
2022-07-294Relay Therapeutics, Inc. (RLAY)Sale (S): 734 @ $21.26EDGAR
2022-06-284Relay Therapeutics, Inc. (RLAY)Sale (S): 300 @ $20.31EDGAR
2022-05-024Relay Therapeutics, Inc. (RLAY)Sale (S): 725 @ $25.57EDGAR
2022-03-314Relay Therapeutics, Inc. (RLAY)Sale (S): 282 @ $29.87EDGAR
2022-03-284Relay Therapeutics, Inc. (RLAY)Option exercise (M): 13,286 @ $4.12 · Sale (S): 13,286 @ $30 · Option exercise (M): 13,286 (derivative) @ $0EDGAR
2022-01-314Relay Therapeutics, Inc. (RLAY)Grant/award (A): 39,270 @ $0 · Grant/award (A): 78,540 (derivative) @ $0EDGAR
2021-12-274Relay Therapeutics, Inc. (RLAY)Sale (S): 295 @ $33.10EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1818261 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs